Lymphosarcoma of the prostate.
KING LS, COX TR.
Am J Pathol. 1951 Sep-Oct;27(5):801-23.
Lymphosarcoma of the prostate.
WALLER JI, SHULLENBERGER WA.
J Urol. 1949 Oct;62(4):480-7. doi: 10.1016/S0022-5347(17)68959-6.
Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease.
Yuan S, Jiang F, Chen J, Lebwohl B, Green PHR, Leffler D, Larsson SC, Li X, Ludvigsson JF.
EBioMedicine. 2024 Mar;101:105033. doi: 10.1016/j.ebiom.2024.105033. Epub 2024 Feb 21.
Primary lymphosarcoma of prostate.
Hampel N, Richter-Levin D, Gersh I.
Urology. 1977 Apr;9(4):461-3. doi: 10.1016/0090-4295(77)90230-8.
Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy.
Sarris A, Dimopoulos M, Pugh W, Cabanillas F.
J Urol. 1995 Jun;153(6):1852-4. doi: 10.1016/s0022-5347(01)67330-0.
Impact of occupational pesticide exposure assessment method on risk estimates for prostate cancer, non-Hodgkin's lymphoma and Parkinson's disease: results of three meta-analyses.
Ohlander J, Fuhrimann S, Basinas I, Cherrie JW, Galea KS, Povey AC, van Tongeren M, Harding AH, Jones K, Vermeulen R, Huss A, Kromhout H.
Occup Environ Med. 2022 Aug;79(8):566-574. doi: 10.1136/oemed-2021-108046. Epub 2022 Apr 7.
Diffuse large B-cell lymphoma of the prostate.
Warrick JI, Owens SR, Tomlins SA.
Arch Pathol Lab Med. 2014 Oct;138(10):1286-9. doi: 10.5858/arpa.2014-0276-CC.
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?
Wahl RL, Kahl B.
Semin Nucl Med. 2024 Jul;54(4):513-529. doi: 10.1053/j.semnuclmed.2024.06.002. Epub 2024 Jul 16.
Non-Hodgkin lymphoma of the prostate.
Steuter J, Weisenburger DD, Bociek RG, Bierman P, Vose J, Bast M, Loberiza F, Armitage JO.
Am J Hematol. 2011 Nov;86(11):952-4. doi: 10.1002/ajh.22150. Epub 2011 Sep 2.
Primary extramedullary leukemia of the prostate: case report and review of the literature.
Quien ET, Wallach B, Sandhaus L, Kidd P, Strair R, Saidi P.
Am J Hematol. 1996 Dec;53(4):267-71. doi: 10.1002/(SICI)1096-8652(199612)53:4<267::AID-AJH13>3.0.CO;2-9.
